Residents in care homes have suffered greatly during the COVID-19 pandemic. Many potential treatments have been proposed that might prevent COVID-19 but none have been tested in care homes. PROTECT-CH is a platform trial that will test one or more treatments with the aim of reducing the risk of care home residents catching the virus that causes COVID-19 and of developing severe disease. We will make the results of the study rapidly available to ensure that treatments can be introduced without delay and COVID-19 guidelines quickly updated.

People living in residential and nursing homes across the UK can take part, but first their care home must be part of the study. If you are a care home manager and want to take part, please complete this survey.

Further information about the study is available in this summary.

Funded by the NIHR logoPROTECT-CH is funded by the National Institute of Health Research. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.

EudraCT number: EudraCT  2021-000185-15


This trial is supported by a grant to the University of Nottingham from UK Research and Innovation/National Institute for Health Research (NIHR).

This trial is being carried out in collaboration with the Universities: Nottingham, Cambridge, Surrey, Edinburgh, Warwick, UCL, QUB, Cardiff